Stocks Health care VCEL
NASDAQ · Health careVericel Corp (VCEL)
Vericel Corp brought in $324.2M of revenue over the twelve months to September 30, 2026, up 25.3% from a year earlier. Net income was $33.3M, a net margin of 10.3%. Operating cash flow minus capital spending left $24.7M of free cash flow in fiscal 2025. At September 30, 2026 it held $133.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Vericel Corp
- Net worth
- Vericel Corp has a market value (market cap) of $3B at the latest share price, and shareholders' equity of $384.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $276.3M (+16.5% year on year), with net income of $16.5M. Over the 12 months to September 30, 2026: revenue $324.2M, net income $33.3M.
- Cash flow
- In fiscal 2025 operations brought in $51.9M of cash; after $27.2M of capital spending, free cash flow was $24.7M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Vericel Corp's next report is expected around January 12, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Vericel Corp does
Vericel Corp is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker VCEL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $276.3M | $16.5M | $0.32 | $24.7M |
| 2024 | $237.2M | $10.4M | $0.20 | -$5.8M |
| 2023 | $197.5M | -$3.2M | -$0.07 | $15.3M |
| 2022 | $164.4M | -$16.7M | -$0.35 | $10.1M |
| 2021 | $156.2M | -$7.5M | -$0.16 | $21.1M |
| 2020 | $124.2M | $2.9M | $0.06 | $14.9M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where VCEL ranks in Health care
Latest SEC filings
What Vericel Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 26% to $85.4M versus the same quarter last year; diluted EPS $0.27 versus $0.10.
- November 5, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- July 30, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 22% to $77.5M versus the same quarter last year; diluted EPS $0.04 versus -$0.01.
- July 30, 2026
- May 18, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 30% to $68.4M versus the same quarter last year; diluted EPS -$0.12 versus -$0.23.
- May 7, 2026
- May 1, 2026
- April 30, 2026Passive stake (5% or more) SCHEDULE 13G
What is VCEL worth? A DCF from its reported cash flow
Insider trades
What the people running Vericel Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $3.8M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 6, 2026 | Mara Joseph Anthony JrChief Financial Officer | Exercised options | 14,068 | $491K |
| November 6, 2026 | Mara Joseph Anthony JrChief Financial Officer | Soldpre-planned (10b5-1) | 14,068 | $751.4K |
| November 6, 2026 | Mara Joseph Anthony JrChief Financial Officer | Exercised options | 14,573 | $434.6K |
| November 6, 2026 | Mara Joseph Anthony JrChief Financial Officer | Soldpre-planned (10b5-1) | 14,573 | $778.6K |
| November 5, 2026 | Mara Joseph Anthony JrChief Financial Officer | Exercised options | 10,932 | $381.5K |
| November 5, 2026 | Mara Joseph Anthony JrChief Financial Officer | Soldpre-planned (10b5-1) | 10,932 | $583.8K |
| November 5, 2026 | Mara Joseph Anthony JrChief Financial Officer | Exercised options | 10,427 | $310.9K |
| November 5, 2026 | Mara Joseph Anthony JrChief Financial Officer | Soldpre-planned (10b5-1) | 10,427 | $560.2K |
Who owns VCEL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 5.11% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 319 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 8,092,226 | +326,882 |
| State Street Corp | 3,293,975 | +141,845 |
| Congress Asset Management Co | 2,916,295 | +1,409,377 |
| Vanguard Capital Management LLC | 2,255,728 | +24,972 |
| Conestoga Capital Advisors, LLC | 2,083,832 | -379,480 |
| William Blair Investment Management, LLC | 1,992,855 | +160,146 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,639,988 | -83,584 |
| Soleus Capital Management, L.P. | 1,459,152 | -1,089,927 |
| Geode Capital Management, LLC | 1,341,244 | +86,382 |
| Geneva Capital Management LLC | 1,339,123 | -307,695 |
| Loomis Sayles & Co L P | 1,200,239 | +224,792 |
| Vanguard Portfolio Management LLC | 1,060,753 | +69,127 |
| Bank of America Corp | 1,016,184 | -82,587 |
| Dimensional Fund Advisors LP | 906,200 | +61,445 |
| Silvercrest Asset Management Group LLC | 896,651 | -62,556 |
| Royal Bank of Canada | 775,762 | -106,400 |
| Champlain Investment Partners, LLC | 755,828 | -59,345 |
| Aberdeen Group plc | 710,238 | +26,113 |
| Nomura Asset Management International Inc. | 664,305 | +33,426 |
| Next Century Growth Investors LLC | 612,584 | +459,805 |
Insiders
13 insiders reported holding 611,074 shares in total, about $35.7M at the last price.
| Holder | Shares |
|---|---|
| Colangelo DominickPresident and CEO, Director | 312,446 |
| Hopper Jonathan MarkChief Medical Officer | 75,753 |
| Rubino Alan LDirector | 64,194 |
| Hagen HeidiDirector | 35,050 |
| Zerbe Robert L MdDirector | 32,995 |
| Wotton Paul KDirector | 18,802 |
| Mclaughlin Kevin FDirector | 18,300 |
| Halpin MichaelChief Operating Officer | 16,394 |
| Mara Joseph Anthony JrChief Financial Officer | 16,186 |
| Wright LisaDirector | 15,851 |
Questions about VCEL
What does Vericel Corp do?
Vericel Corp is a company in the Health care sector, listed on NASDAQ as VCEL. Its shares trade on NASDAQ under the ticker VCEL.
What is Vericel Corp's net worth?
Vericel Corp has a market value (market cap) of $3B at the latest share price, and shareholders' equity of $384.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Vericel Corp profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $33.3M on revenue of $324.2M, a net margin of 10.3%.
How much revenue does Vericel Corp make?
Over the twelve months to September 30, 2026 Vericel Corp reported revenue of $324.2M. That is 25.3% more than a year earlier.
When did Vericel Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the planned insider sale from November 9, 2026.
When is Vericel Corp's next earnings report?
Vericel Corp's next report is expected around January 12, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare VCEL with
Follow VCEL
Get an email when Vericel Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Vericel Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.